144 related articles for article (PubMed ID: 18370844)
1. Pharmacogenomics of metabolic effects of rosiglitazone.
Seda O; Sedová L; Oliyarnyk O; Kazdová L; Krenová D; Corbeil G; Hamet P; Tremblay J; Kren V
Pharmacogenomics; 2008 Feb; 9(2):141-55. PubMed ID: 18370844
[TBL] [Abstract][Full Text] [Related]
2. Rosiglitazone fails to improve hypertriglyceridemia and glucose tolerance in CD36-deficient BN.SHR4 congenic rat strain.
Seda O; Kazdova L; Krenova D; Kren V
Physiol Genomics; 2003 Jan; 12(2):73-8. PubMed ID: 12429866
[TBL] [Abstract][Full Text] [Related]
3. Rosiglitazone improves insulin resistance, lipid profile and promotes adiposity in a genetic model of metabolic syndrome X.
Seda O; Kazdová L; Krenová D; Kren V
Folia Biol (Praha); 2002; 48(6):237-41. PubMed ID: 12512799
[TBL] [Abstract][Full Text] [Related]
4. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
5. Dietary sardine protein lowers insulin resistance, leptin and TNF-α and beneficially affects adipose tissue oxidative stress in rats with fructose-induced metabolic syndrome.
Madani Z; Louchami K; Sener A; Malaisse WJ; Ait Yahia D
Int J Mol Med; 2012 Feb; 29(2):311-8. PubMed ID: 22085913
[TBL] [Abstract][Full Text] [Related]
6. Prominent role of liver in elevated plasma palmitoleate levels in response to rosiglitazone in mice fed high-fat diet.
Kuda O; Stankova B; Tvrzicka E; Hensler M; Jelenik T; Rossmeisl M; Flachs P; Kopecky J
J Physiol Pharmacol; 2009 Dec; 60(4):135-40. PubMed ID: 20065507
[TBL] [Abstract][Full Text] [Related]
7. Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model.
Sharabi Y; Oron-Herman M; Kamari Y; Avni I; Peleg E; Shabtay Z; Grossman E; Shamiss A
Am J Hypertens; 2007 Feb; 20(2):206-10. PubMed ID: 17261469
[TBL] [Abstract][Full Text] [Related]
8. Differential modulatory effects of rosiglitazone and pioglitazone on white adipose tissue in db/db mice.
Yang KJ; Noh JR; Kim YH; Gang GT; Hwang JH; Yang SJ; Yeom YI; Lee CH
Life Sci; 2010 Sep; 87(13-14):405-10. PubMed ID: 20723549
[TBL] [Abstract][Full Text] [Related]
9. Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance.
Lessard SJ; Rivas DA; Chen ZP; Bonen A; Febbraio MA; Reeder DW; Kemp BE; Yaspelkis BB; Hawley JA
Diabetes; 2007 Jul; 56(7):1856-64. PubMed ID: 17440174
[TBL] [Abstract][Full Text] [Related]
10. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia.
Berthiaume M; Laplante M; Tchernof A; Deshaies Y
Int J Obes (Lond); 2007 Nov; 31(11):1660-70. PubMed ID: 17579631
[TBL] [Abstract][Full Text] [Related]
11. Metabolic characterization of insulin resistance syndrome feature loci in three brown Norway-derived congenic strains.
Seda O; Sedová L; Kazdová L; Krenová D; Kren V
Folia Biol (Praha); 2002; 48(3):81-8. PubMed ID: 12118727
[TBL] [Abstract][Full Text] [Related]
12. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.
Oakes ND; Kennedy CJ; Jenkins AB; Laybutt DR; Chisholm DJ; Kraegen EW
Diabetes; 1994 Oct; 43(10):1203-10. PubMed ID: 7926289
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between adipose phosphoenolpyruvate carboxykinase and occurrence and reversion of insulin resistance].
Zhao WH; Xiao JZ; Yang WY; Wang N; Wang X; Chen XP; Bu S
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3074-8. PubMed ID: 16324411
[TBL] [Abstract][Full Text] [Related]
14. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
[TBL] [Abstract][Full Text] [Related]
15. Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy.
Sutinen J; Kannisto K; Korsheninnikova E; Fisher RM; Ehrenborg E; Nyman T; Virkamäki A; Funahashi T; Matsuzawa Y; Vidal H; Hamsten A; Yki-Järvinen H
Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E941-9. PubMed ID: 14749206
[TBL] [Abstract][Full Text] [Related]
16. Weight gain induced by high-fat feeding involves increased liver oxidative stress.
Milagro FI; Campión J; Martínez JA
Obesity (Silver Spring); 2006 Jul; 14(7):1118-23. PubMed ID: 16899792
[TBL] [Abstract][Full Text] [Related]
17. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
Sugiyama Y; Taketomi S; Shimura Y; Ikeda H; Fujita T
Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
[TBL] [Abstract][Full Text] [Related]
19. High fat and highly thermolyzed fat diets promote insulin resistance and increase DNA damage in rats.
de Assis AM; Rieger DK; Longoni A; Battu C; Raymundi S; da Rocha RF; Andreazza AC; Farina M; Rotta LN; Gottfried C; Gonçalves CA; Moreira JC; Perry ML
Exp Biol Med (Maywood); 2009 Nov; 234(11):1296-304. PubMed ID: 19855071
[TBL] [Abstract][Full Text] [Related]
20. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
